pharmaphorum

AUGUST 17, 2022

The latest life science competitiveness indicators (LSCIs) were published by the Office of Life Sciences (OLS) in July 2022. Indicators from the 2000s were captured in the Pharmaceutical Industry Competitiveness Task Force (PICTF) Indicators. The post UK life science competitiveness indicators 2022: measuring what matters most?

Competition 57

Competition Medicine Patients Government 57

MedCity News

NOVEMBER 26, 2023

While current government and commercial efforts to negotiate competitive drug prices are important, this focus represents a minor—and misplaced—implementation of medication management. It’s time that policymakers, insurers and healthcare providers make pharmacogenomic testing a fundamental standard of care delivery.

Healthcare 86

Healthcare Healthcare Insurance Healthcare Provider 86

MedCity News

SEPTEMBER 15, 2022

The complaint alleged that RWJBarnabas conspired with real estate investors, New Jersey’s largest payer and government officials to eliminate competition and monopolize acute care services in the state.

Government 108

Government Competition 108

pharmaphorum

NOVEMBER 25, 2022

The latest market study report from the Competition Bureau has provided recommendations to health care providers (HCPs) on how to improve the ways they work within Canada’s public health system. The new report states that digital health care is not being used to its full potential in Canada.

Competition 52

Competition Government Physicians Marketing 52

pharmaphorum

DECEMBER 15, 2022

A pharma industry organisation has warned that record levels of revenue clawback from the UK government is threatening “footprint, R&D and manufacturing investments” in the country. billion (around $4 billion) in revenue to the government – 26.5% Returns have risen sharply from £0.6 billion in 2021 to £1.8

Pharma 70

Pharma Government Manufacturing Competition 70

Clarivate

APRIL 27, 2023

has a diverse and extensive research landscape, with government agencies, universities, and private companies playing a significant role in funding and conducting research. The research landscape is highly competitive on the global stage, with a focus on driving innovation and making breakthroughs. For many years the U.S.

Competition 105

Competition Engineering Government Networking 105

European Pharmaceutical Review

JUNE 8, 2023

A new report by the Association of the British Pharmaceutical Industry (ABPI) has identified the UK biopharma industry is increasingly seeking talent with artificial intelligence (AI) and data skills to maintain competitiveness as digital technology continues to drive innovation.

Biopharma 83

Biopharma Government Training Education 83

pharmaphorum

JANUARY 16, 2023

Since 2014, the repayment percentage detailed in the VPAS and predecessor the PPRS averaged at around 7%, but skyrocketed to 19% in 2022 ahead of a government-agreed cap at 15%, and rose again to 26.5% The ABPI said that exposes “the depth of feeling that the current voluntary scheme is damaging the UK life sciences industry.”

Government 67

Government Medicine Consulting Management 67

European Pharmaceutical Review

JANUARY 2, 2024

The report recommened that to gain a competitive edge in the market, focusing on modernising R&D models or implementing emerging technologies could support this endeavour. The pharmaceutical industry will need to innovate and increase resilience to accelerate market expansion, the company highlighted.

Pharma 80

Pharma Government Medicine Marketing 80

World of DTC Marketing

OCTOBER 5, 2021

Seventy-nine percent of Americans think the price of prescription drugs is “unreasonable,” according to a 2019 Kaiser Family Foundation poll , and about 9 in 10 say they support the idea of the government negotiating prices. Via Axios “The 10 highest-selling drugs in the U.S. sales revenue more than triple the rest of the world.

Pharma 241

Pharma Insurance Sales Government 241

European Pharmaceutical Review

JUNE 14, 2023

With manufacturing investment competition intensifying worldwide in recent years, the UK’s position as a manufacturing leader has declined. Additionally, the government recently announced to the creation of a Biomanufacturing Fund. This is compared to 13 percent (£4.8 billion) from life science research and 42 percent (£15.7

Medicine 52

Medicine Manufacturing Government Competition 52

Pharmaceutical Technology

OCTOBER 5, 2022

Bringing an end to a 13-year deliberation on a whistleblower lawsuit, Biogen recently agreed to pay a $900 million settlement , amidst increased government alertness on pharmaceutical fraud. However, new MS drugs like Novartis ’ Gilenya, were going to soon enter the market and increase competition within the MS therapeutic landscape.

Government 59

Government Specialization Physicians Education 59

Clarivate

NOVEMBER 16, 2021

We’re pleased to showcase some institutions that excel in a competitive global environment, supporting their Highly Cited Researchers in a way that encourages collaboration, facilitates career growth and accelerates highly innovative research. The National University of Singapore (NUS) is home to 32 Highly Cited Researchers in 2021.

Government 136

Government Competition Recruitment Leads 136

pharmaphorum

JULY 22, 2022

A just-published report on the UK’s life sciences sector “ought to ring alarm bells across government,” according to the Association of the British Pharmaceutical Industry (SBPI). The Life Sciences Competitiveness Indicators report shows that spending on life sciences R&D was £2.7 Draft finance bill.

Government 52

Government Medicine Recruitment Competition 52

Clarivate

FEBRUARY 10, 2022

Government and academic research institutions and corporate businesses were all included. Top innovators in South and Southeast Asia : India tops the list with the most innovators from government research institutions, academic institutions and corporations segment. Key findings from our report.

Government 52

Government Competition Engineering Manufacturing 52

pharmaphorum

JANUARY 27, 2023

Governments will act, but will it be enough? While the price-setting mechanism varies across markets, prices everywhere are ultimately determined by either governments or other powerful intermediaries. In any case, there is only so much that companies can do on their own – which brings us to the third likely trend for 2023.

Medicine 85

Medicine Government Marketing Transportation 85

The Brooks Group

SEPTEMBER 9, 2014

When prospects are comparing your proposal to the competition in an attempt to create a bidding war, the buyer is working to further put themselves in the driver's seat and get the lowest price they can. How to Differentiate When Prospects are Comparing Your Proposal to the Competition. The Problem With Comparing Quotes.

Prospecting 40

Prospecting Competition Sales Government 40

World of DTC Marketing

JULY 21, 2021

Drug pricing is done by internal teams who look at what the market will bear and the competitive landscape. If drug prices are to come down, the federal government needs to negotiate drug prices for Medicare, and a new breed of CEO, who really puts patients first, needs to take control. Again this is not true.

Marketing 285

Marketing Prescription Side effects Doctors 285

Clarify Health

SEPTEMBER 29, 2023

CoEs can be established by a variety of entities, including healthcare organizations, medical institutions, government agencies, and sometimes private entities. Building on the success of this project, the benefits administrator’s team is now working with Clarify Health to understand and optimize their competitive position in target markets.

Networking 52

Networking Healthcare Healthcare Competition 52

Pharmaceutical Technology

JUNE 12, 2023

GlobalData’s Internet of Things market report helps keep abreast of the latest trends in Internet of Things, market opportunity forecast and the competitive landscape. Buy the report here.

Pharmaceutical 52

Pharmaceutical Government Competition Marketing 52

PM360

JUNE 26, 2023

This can be especially important in the current global economic climate, where competition for market share is fierce, and access to new customers is critical for growth. This includes ensuring access and affordability of their products, which can positively impact their environmental social governance (ESG) score and reputation.

Medicine 98

Medicine Marketing Pharma Manufacturing 98

pharmaphorum

OCTOBER 20, 2022

Together, these groups compile vast amounts of data, including rich information on patient populations, target customers, and the competitive landscape. Historically, competitive and market analysis data has been stored in spreadsheets. Truly understanding the competitive landscape and market environment.

Competition 88

Competition Marketing Pharma Biopharma 88

World of DTC Marketing

MAY 26, 2021

Here is the executive summary of the Government’s report on AbbVie. AbbVie has obtained or applied for over 250 patents on Humira to block competition from lower-priced biosimilars. SUMMARY: Sometimes there are just no words to express my outrage. I’m disgusted, sad , and angry.

Competition 180

Competition Marketing Government Patients 180

Pharmaceutical Technology

OCTOBER 17, 2022

The UK Government has announced funding worth more than $894.6m (£800m) to back research into ground-breaking, experimental therapies and progress the response of the country to patient safety challenges.

Safety 52

Safety Government Competition Patients 52

Pharmaceutical Technology

JULY 21, 2022

As part of ESG (Environmental, Social, and Governance), the social good delivered by robust healthcare systems are at the core of healthy populations. This is an edited extract from the ESG (Environmental, Social, and Governance) Top Trends by Sector – Thematic Research report produced by GlobalData Thematic Research.

Government 52

Government Healthcare Healthcare Pharma 52

PM360

APRIL 7, 2023

What other policy issues or potential changes by the government should companies be aware of? However, we expect drugs without strong therapeutic alternatives to have an advantage in negotiations, while drugs in highly competitive classes will be negotiating from a weaker position.

Manufacturing 97

Manufacturing Insurance Government Marketing 97

Pharmaceutical Technology

NOVEMBER 22, 2022

China will continue to take steps towards becoming as competitive in high-value innovative pharma as it is in the generics industry, with The Wall Street Journal reporting Chinese biotechs raised $1.6tn through 568 venture financings last year, up from $11bn in 418 deals in 2020.

Manufacturing 64

Manufacturing Pharma Government FDA 64

Clarivate

AUGUST 2, 2023

Despite a steady increase in overall funding budgets, the actual size of individual grants and success rates have remained relatively stagnant, indicating a complex and fiercely competitive funding landscape. The organization’s recent outreach efforts across the U.K. Yet, these challenges are not insurmountable.

Competition 98

Competition Networking Management Leads 98

European Pharmaceutical Review

SEPTEMBER 7, 2023

Under original terms of association, this was not the case, according to the UK government. The country will be compensated should its scientists receive significantly less money than the country puts into the programme.

Government 80

Government Competition Pharmaceutical Manufacturing 80

Contrarian Sales Techniques

FEBRUARY 26, 2023

These countries, known as "compulsory licensing" countries, have laws that allow the government to issue licenses to local companies to produce generic versions of patented drugs without the patent holder's permission. Some examples of compulsory licensing countries include India, Brazil, and South Africa.

Pharmaceutical 52

Pharmaceutical Medicine Government Side effects 52

Curzon Consulting

MARCH 8, 2024

Businesses should prioritise data security, governance, and utilisation for informed decision-making. Leaders must prioritise reforming their operating models, to remain competitive and building a solid foundation before layering on technology.

Consulting 40

Consulting Competition Ethics Management 40

Spotio

FEBRUARY 21, 2023

The goals are to increase quality, decrease costs and turn health care into a competitive marketplace. However, the safe harbors that govern medical device sales are being revised by the Office of the Inspector General. Healthcare as a competitive market is a new idea. Expect short term upheaval and long term economic impacts.

Medical sales 52

Medical sales Medical Sales Physicians 52

European Pharmaceutical Review

JULY 15, 2022

The four governments of the UK established the scheme to increase the climate ambition of the UK’s carbon pricing policy, whilst also protecting the competitiveness of UK businesses. On 1 January 2021, a UK Emissions Trading Scheme (UK ETS) replaced the UK’s participation in the European Union (EU) ETS.

Pharmaceutical manufacturing 94

Pharmaceutical manufacturing Manufacturing Pharmaceutical Government 94

pharmaphorum

NOVEMBER 17, 2022

Predictable for government. The 2019 VPAS deal was struck as a negotiation between DHSC, NHS England, the devolved nations, as well as others on the side of the government and industry body, the ABPI. The 2019 VPAS , just like its predecessor that was in place from 2014, has at its heart a payback mechanism. More transparency needed.

Government 95

Government Sales Medicine Consulting 95

Pharmaceutical Technology

NOVEMBER 4, 2022

Consistent government action needed. For the life sciences and pharmaceutical sector, the Conservative government promised £34 billion ($38.98 The government’s actions on funding remain critical for small to medium enterprises (SMEs) like Ochre. UK’s competitive potential. says O’Meara.

Pharma 93

Pharma Government Pharmaceutical Medicine 93

Clarivate

MARCH 8, 2022

In today’s competitive academic environment, it is possible to overemphasize the importance of immediate results and performance. However, we hope that through our annual financial funding competition, our scholars can develop their long-term scientific research without any funding restrictions.

Engineering 98

Engineering Government Competition Networking 98

MedReps

SEPTEMBER 19, 2022

Often we’re lucky if we even get to see our physicians, let alone overcome their objections regarding insurance coverage and competitive claims. On the other hand, if your product is similar to the competition, get your physician’s attention with your product’s affordability and ease of use.

Medical sales 66

Medical sales Medical sales reps Medical Sales 66